SBIR/STTR Research Award

A PERFUSION TEST FOR DETECTING THE AGENT OF LYME DISEASE

Award identifier 89e44c7716e2d00f010322ddfd7a9f91cdddb825fc8b19b46987ae952303193fAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1991

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
IMMUNETICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE OBJECTIVE OF THE WORK IS TO DETERMINE WHETHER A NOVEL PROPRIETARY DEVICE DESIGNED TO DETECT ACTIVE LYME DISEASE SPIROCHETAL INFECTION CAN BE EXPLOITED COMMERCIALLY. THIS DEVICE IS INTENDED TO PERFUSE THE SKIN OF A PATIENT AND AUTOMATICALLY DELIVER THE SAMPLE INTO A VESSEL CONTAINING CULTURE MEDIUM. IN PHASE I OF THIS PROJECT, VARIOUS PROTOTYPE MODELS OF THE PERFUSION DEVICE WILL BE CONSTRUCTED AND TESTED. THE DIAGNOSTIC SENSITIVITY OF THE PROCEDURE WILL BE EVALUATED IN MICE, RABBITS AND PIGS. DURING PHASE II, THE DEVICE WILL BE EVALUATED USING HUMAN PATIENTS AND ITS CLINICAL UTILITY EXPLORED AT A SITE IN WHICH THE TRANSMISSION OF LYME DISEASE IS INTENSE. THIS COLLABORATIVE PROJECT LINKS AN ACADEMIC LABORATORY THAT HAS BEEN PROMINENT IN WORK ON THE BIOLOGY OF LYME DISEASE WITH A COMMERCIAL LABORATORY EXPERIENCED IN THE DEVELOPMENT AND MARKETING OF DIAGNOSTIC PRODUCTS. THE OBJECTIVE OF THE WORK IS TO DETERMINE WHETHER A NOVEL PROPRIETARY DEVICE DESIGNED TO DETECT ACTIVE LYME DISEASE SPIROCHETAL INFECTION CAN BE EXPLOITED COMMERCIALLY. THIS DEVICE IS INTENDED TO PERFUSE THE SKIN OF A PATIENT AND AUTOMATICALLY DELIVER THE SAMPLE INTO A VESSEL CONTAINING CULTURE MEDIUM. IN PHASE I OF THIS PROJECT, VARIOUS PROTOTYPE MODELS OF THE PERFUSION DEVICE WILL BE CONSTRUCTED AND TESTED. THE DIAGNOSTIC SENSITIVITY OF THE PROCEDURE WILL BE EVALUATED IN MICE, RABBITS AND PIGS. DURING PHASE II, THE DEVICE WILL BE EVALUATED USING HUMAN PATIENTS AND ITS CLINICAL UTILITY EXPLORED AT A SITE IN WHICH THE TRANSMISSION OF LYME DISEASE IS INTENSE. THIS COLLABORATIVE PROJECT LINKS AN ACADEMIC LABORATORY THAT HAS BEEN PROMINENT IN WORK ON THE BIOLOGY OF LYME DISEASE WITH A COMMERCIAL LABORATORY EXPERIENCED IN THE DEVELOPMENT AND MARKETING OF DIAGNOSTIC PRODUCTS.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.